Zaidi Zoubida and Hamdi Cherif Mokhtar
Posters-Accepted Abstracts: J Cancer Sci Ther
Purpose: More than 1.1 million cases of prostate cancer were recorded in 2012 accounting for around 8% of all new cancer cases and 15% in men. About 68% of prostate cancer cases occurred in more developed countries. An increasing trend in incidence is reported from various registries of Arab world. This study describes the trends of the survival of prostate cancer patients diagnosed in 1995-2009 in 06 populations based cancer registries in Arab countries. Methods: This report is a summary of the latest survival figures of CONCORD 2 ??Global surveillance of cancer survival 1995-2009?. Individual prostate tumor records were submitted by 06 population-based cancer registries in Arab countries (Jordan, Saoudi Arabia, Qatar, Algeria, Lybia and Tunisia) for 3552 men (15-99 years) diagnosed during 1995-2009 and followed up to 31 December 2009. Estimated five-year net survival adjusted for background mortality by single year of age, sex, calendar year in each country. Results: For men diagnosed during 2005-2009, age-standardized five-year net survival was extraordinarily wide from less than 40% to greater than 95%. In Arab countries prostate cancer survival was higher 61% in Saudi Arabia and less in Libya 39%. Conclusions: Comparison of population-based cancer survival CONCORD study 2 showed very wide variations in survival from cancer of prostate in Arab world. Cancer survival research is being used to formulate cancer control and the need to implement effective strategies of primary prevention.
Cancer Science & Therapy received 5282 citations as per Google Scholar report